• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在大鼠卵巢肿瘤细胞系中,与顺铂耐药性发展相关的从异倍体到近二倍体的核型变化。

Karyotypic change from heteroploidy to near diploidy associated with development of cisplatin resistance in a rat ovarian tumour cell line.

作者信息

Chen G, Hutter K J, Bullerdiek J, Zeller W J

机构信息

Institute of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg.

出版信息

J Cancer Res Clin Oncol. 1991;117(6):539-42. doi: 10.1007/BF01613285.

DOI:10.1007/BF01613285
PMID:1744159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12201834/
Abstract

In a rat ovarian tumour cell line a 33-fold resistance to cisplatin (O-342/DDP) was developed in vitro by continuous exposure of the parental cell line (O-342) to stepwise increase cisplatin concentration in the culture medium. Both cell lines had a similar growth rate in vitro. Development of resistance was accompanied by a change of the karyotype from heteroploidy in chemosensitive O-342 cells to near diploidy in resistant O-342/DDP cells as shown by chromosome number distribution. This finding was confirmed by measuring cellular DNA content using flow-cytometry analysis. Flow karyotyping showed significant differences in chromosomal DNA contents between both cell lines. Our results suggest that the parent line O-342 consists of at least two subpopulations, a cisplatin-sensitive and a cisplatin-resistant one, corresponding to hyperploidy and near diploidy, respectively. Continuous cisplatin exposure of O-342 cells selectively killed the sensitive fraction, resulting in the karyotypic change observed.

摘要

在一个大鼠卵巢肿瘤细胞系中,通过将亲代细胞系(O-342)持续暴露于培养基中逐步增加的顺铂浓度,在体外诱导出了对顺铂33倍的抗性(O-342/DDP)。两种细胞系在体外具有相似的生长速率。抗性的产生伴随着核型的改变,即从化疗敏感的O-342细胞中的异倍体变为抗性的O-342/DDP细胞中的近二倍体,这通过染色体数目分布得以显示。通过流式细胞术分析测量细胞DNA含量证实了这一发现。流式核型分析显示两种细胞系之间染色体DNA含量存在显著差异。我们的结果表明,亲代细胞系O-342至少由两个亚群组成,一个是顺铂敏感亚群,一个是顺铂抗性亚群,分别对应超倍体和近二倍体。O-342细胞持续暴露于顺铂会选择性地杀死敏感部分,从而导致观察到的核型变化。

相似文献

1
Karyotypic change from heteroploidy to near diploidy associated with development of cisplatin resistance in a rat ovarian tumour cell line.在大鼠卵巢肿瘤细胞系中,与顺铂耐药性发展相关的从异倍体到近二倍体的核型变化。
J Cancer Res Clin Oncol. 1991;117(6):539-42. doi: 10.1007/BF01613285.
2
In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line.大鼠卵巢肿瘤细胞系中顺铂耐药性诱导及逆转的体外研究
J Cancer Res Clin Oncol. 1990;116(5):443-7. doi: 10.1007/BF01612991.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
4
In vivo establishment and characterization of a paclitaxel-resistant human ovarian cancer cell line showing enhanced growth properties and drug-resistance only in vivo.一种仅在体内表现出增强生长特性和耐药性的紫杉醇耐药人卵巢癌细胞系的体内建立与表征
J Cancer Res Clin Oncol. 2004 Mar;130(3):178-86. doi: 10.1007/s00432-003-0516-9. Epub 2003 Dec 4.
5
Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.紫杉醇对顺铂敏感和耐药的人卵巢癌细胞系顺铂敏感性的调节作用
J Cancer Res Clin Oncol. 2000 Mar;126(3):168-72. doi: 10.1007/s004320050027.
6
Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.转录因子YB-1在获得性顺铂耐药卵巢癌中的核定位增加。
J Cancer Res Clin Oncol. 2002 Nov;128(11):621-6. doi: 10.1007/s00432-002-0386-6. Epub 2002 Oct 22.
7
CircASH1L inhibits ferroptosis and enhances cisplatin resistance by sponging miR-515-5p to regulate cell cycle-related CDCA7/RRM2 in ovarian cancer cells.环状RNA ASH1L通过吸附miR-515-5p调控卵巢癌细胞中细胞周期相关蛋白CDCA7/RRM2,从而抑制铁死亡并增强顺铂耐药性。
Front Pharmacol. 2025 Jun 24;16:1563869. doi: 10.3389/fphar.2025.1563869. eCollection 2025.
8
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
9
Radiation sensitivities in various anticancer-drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line.多种抗癌药耐药的人肺癌细胞系的辐射敏感性及顺铂耐药细胞系中的辐射交叉耐药机制
J Cancer Res Clin Oncol. 1992;119(1):28-34. doi: 10.1007/BF01209484.
10
Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines--with special reference to cisplatin.聚(ADP - 核糖)聚合酶抑制剂与DNA损伤剂在卵巢肿瘤细胞系中的联合效应——特别提及顺铂
J Cancer Res Clin Oncol. 1996;122(11):665-70. doi: 10.1007/BF01209029.

引用本文的文献

1
Cell cycle effects of thaliblastine.thaliblastine的细胞周期效应
J Cancer Res Clin Oncol. 1996;122(11):707-10. doi: 10.1007/BF01209037.
2
Positive correlation between cellular glutathione and acquired cisplatin resistance in human ovarian cancer cells.人卵巢癌细胞中细胞内谷胱甘肽与获得性顺铂耐药性之间的正相关。
Cell Biol Toxicol. 1995 Oct;11(5):273-81. doi: 10.1007/BF00757625.
3
Reversal of acquired cisplatin resistance by nicotinamide in vitro and in vivo.烟酰胺在体外和体内逆转获得性顺铂耐药性
Cancer Chemother Pharmacol. 1993;33(2):157-62. doi: 10.1007/BF00685335.
4
Inhibition of O6-alkylguanine-DNA alkyltransferase in animal and human ovarian tumor cell lines by O6-benzylguanine and sensitization to BCNU.O6-苄基鸟嘌呤对动物和人类卵巢肿瘤细胞系中O6-烷基鸟嘌呤-DNA烷基转移酶的抑制作用及对卡莫司汀的增敏作用。
Cancer Chemother Pharmacol. 1995;35(3):262-6. doi: 10.1007/BF00686559.

本文引用的文献

1
A reliable preparation of mon-dispersed chromosome suspensions for flow cytometry.
Histochemistry. 1982;74(1):57-61. doi: 10.1007/BF00495052.
2
DNA constancy in heteroploidy and the stem line theory of tumors.异倍体中的DNA恒定性与肿瘤的干细胞系学说
Science. 1971 Nov 12;174(4010):714-7. doi: 10.1126/science.174.4010.714.
3
Genetic instability in the development of drug resistance.耐药性发展过程中的基因不稳定性。
Semin Oncol. 1985 Sep;12(3):222-30.
4
Tumor heterogeneity and drug resistance.肿瘤异质性与耐药性。
J Clin Oncol. 1986 Feb;4(2):244-57. doi: 10.1200/JCO.1986.4.2.244.
5
Detection and separation of the submetacentric marker chromosome of the WALKER (W-256) carcinoma using flow cytometry and sorting.使用流式细胞术和分选技术检测并分离沃克(W-256)癌的亚中着丝粒标记染色体。
Histochemistry. 1985;82(5):469-75. doi: 10.1007/BF02450482.
6
Resistance to cisplatin and analogues: mechanisms and potential clinical implications.对顺铂及其类似物的耐药性:机制及潜在临床意义。
Cancer Chemother Pharmacol. 1988;22(4):325-32. doi: 10.1007/BF00254240.
7
Chromosome error propagation and cancer.染色体错误传播与癌症。
Trends Genet. 1989 Feb;5(2):42-5. doi: 10.1016/0168-9525(89)90020-6.
8
In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line.大鼠卵巢肿瘤细胞系中顺铂耐药性诱导及逆转的体外研究
J Cancer Res Clin Oncol. 1990;116(5):443-7. doi: 10.1007/BF01612991.
9
Influence of cisplatin on cell-cycle progression in xenografted human head and neck carcinomas.顺铂对人源头颈癌异种移植瘤细胞周期进程的影响。
Cancer Chemother Pharmacol. 1991;27(6):464-71. doi: 10.1007/BF00685161.
10
Chromosomes and cancer.
Hereditas. 1977;86(1):15-30. doi: 10.1111/j.1601-5223.1977.tb01208.x.